Alan Hay
0000-0002-6064-6183
Publication & Citation Trends
Publications
0 total
Fexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis OA
Cited by 1
Semantic Scholar
PUK13 FEXAPOTIDE TRIFLUTATE VERSUS PHARMACOTHERAPY AS INITIAL THERAPY FOR PATIENTS WITH MODERATE-TO-SEVERE BENIGN PROSTATE HYPERPLASIA: A COST-EFFECTIVENESS ANALYSIS OA
Cited by 0
Semantic Scholar
Inflammatory Bowel Disease: Medical Cost Algorithms OA
Cited by 119
Semantic Scholar
Inflammatory Bowel Disease: Costs‐of-Illness OA
Cited by 235
Semantic Scholar
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
Cited by 1,054
Semantic Scholar
Research Topics
Influenza Virus Research Studies
(150)
Respiratory viral infections research
(71)
Animal Disease Management and Epidemiology
(28)
RNA and protein synthesis mechanisms
(25)
HIV/AIDS drug development and treatment
(19)
Affiliations
Université Claude Bernard Lyon 1
Centers for Disease Control and Prevention
World Health Organization - Pakistan
Centre National de la Recherche Scientifique
Institut national de recherche en sciences et technologies du numérique